| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 07/19/2000 | EP1020517A1 Gene originating in human chondrocyte |
| 07/19/2000 | EP1019728A1 Method of activating a novel ligand regulatory pathway |
| 07/19/2000 | EP1019518A1 Self-deleting vectors for cancer therapy |
| 07/19/2000 | EP1019517A2 Production of proteins in plant seeds |
| 07/19/2000 | EP1019514A1 A keratinocyte derived protease |
| 07/19/2000 | EP1019513A1 Ikr-1 and ikr-2, protein kinases which are related to the i kappa b kinases |
| 07/19/2000 | EP1019512A1 Method for producing branched fatty acids using genetically modified plants |
| 07/19/2000 | EP1019509A2 Protein involved in abscisic acid signalling |
| 07/19/2000 | EP1019508A1 Tnf-related death ligand |
| 07/19/2000 | EP1019506A1 101 human secreted proteins |
| 07/19/2000 | EP1019504A1 Isoforms of the human vitamin d receptor |
| 07/19/2000 | EP1019503A1 Tango-71, tango-73, tango-74, tango-76, and tango-83 nucleic acid molecules and polypeptides |
| 07/19/2000 | EP1019502A2 Human orphan receptor ntr-1 |
| 07/19/2000 | EP1019500A2 Novel ifn receptor 1 binding proteins, dna encoding them, and methods of modulating cellular response to interferons |
| 07/19/2000 | EP1019499A2 Methods and compositions for inducing tumor-specific cytotoxicity |
| 07/19/2000 | EP1019495A1 Transgenic model comprising tcr alpha and beta chains |
| 07/19/2000 | EP1019494A1 Stimulation of hematopoietic cells in vitro |
| 07/19/2000 | EP1019493A1 Generation of hematopoietic cells from multipotent neural stem cells |
| 07/19/2000 | EP1019492A1 Tissue-engineered constructs |
| 07/19/2000 | EP1019491A1 Production of avian embryonic germ (eg) cell lines by prolonged culturing of pgcs, use thereof for cloning and chimerization |
| 07/19/2000 | EP1019490A2 Methods for modulating hematopoiesis and vascular growth |
| 07/19/2000 | EP1019489A1 Application of shear flow stress to chondrocytes |
| 07/19/2000 | EP1019482A1 Soaps produced from high laurate canola oil-based fatty acids |
| 07/19/2000 | EP1019436A1 Acquired resistance npr genes and uses thereof |
| 07/19/2000 | EP1019432A1 The ob receptor and methods of diagnosing and treating weight |
| 07/19/2000 | EP1019431A1 Novel rnase p |
| 07/19/2000 | EP1019104A1 Cell culture products |
| 07/19/2000 | EP1019092A1 Therapeutic and diagnostic tools for impaired glucose tolerance conditions |
| 07/19/2000 | EP1019091A1 50 human secreted proteins |
| 07/19/2000 | EP1019081A2 Apolipoprotein e/growth factor complexes and methods of use |
| 07/19/2000 | EP1019080A2 Modulation of lerk-2-mediated cell adhesion |
| 07/19/2000 | EP1019073A1 Apolipoprotein a-i agonists and their use to treat dyslipidemic disorders |
| 07/19/2000 | EP1019071A2 Random peptides that bind to gastro-intestinal tract (git) transport receptors and related methods |
| 07/19/2000 | EP1019065A1 Multiple target hybridizing nucleic acids, their preparation, compositions, formulation, kits and applications |
| 07/19/2000 | EP1019028A1 $i(CHLAMYDIA) PROTEIN, GENE SEQUENCE AND USES THEREOF |
| 07/19/2000 | EP1018987A1 Neocartilage and methods of use |
| 07/19/2000 | EP1018979A1 Chemical cleaning of biological material |
| 07/19/2000 | EP1018884A1 METHOD OF TREATING BLINDNESS WITH hNT HUMAN NEURONAL CELLS |
| 07/19/2000 | EP1018866A1 Compositions and methods for the preservation of living tissues |
| 07/19/2000 | EP1018863A1 Toxin genes from the bacteria xenorhabdus nematophilus and photorhabdus luminescens |
| 07/19/2000 | EP0900002A4 H2-m modified transgenic animals |
| 07/19/2000 | EP0871354A4 Hypersensitive response induced resistance in plants |
| 07/19/2000 | CN1260837A Plant GRAB proteins |
| 07/19/2000 | CN1260835A Truncated vegf-related proteins |
| 07/19/2000 | CN1260834A Antimicrobial peptide |
| 07/19/2000 | CN1260833A LAG-3 splice variants |
| 07/19/2000 | CN1260831A Chlorella virus prompters |
| 07/19/2000 | CN1054609C Monoclonal antibody of human combining mosaic for recognizing epidermal growth factor receptor |
| 07/18/2000 | US6090929 Polynucleotide coding a cyclic adenosine monophosphate-dependent kinase binding polypeptide; for recombinant production of the kinase binding domain polypeptides; for treatment of myasthenia gravis |
| 07/18/2000 | US6090924 Human-Human CLNH5-specific antibodies |
| 07/18/2000 | US6090923 Immunoglobulin that preferentially binds a human cytotoxin; for the treatment of virus infected or tumor target cells |
| 07/18/2000 | US6090914 CTLA4/CD28Ig hybrid fusion proteins and uses thereof |
| 07/18/2000 | US6090790 Gene delivery by microneedle injection |
| 07/18/2000 | US6090782 Contacting hematopoietic cells with a stem cell proliferation inhibition amount of a peptide or polypeptide having specific amino acid sequence |
| 07/18/2000 | US6090778 Neurturin and related growth factors |
| 07/18/2000 | US6090625 Method of increasing the relative number of CD34+ cells in a cell population |
| 07/18/2000 | US6090624 Immortalized retinal cell lines and their applications |
| 07/18/2000 | US6090622 Human embryonic pluripotent germ cells |
| 07/18/2000 | US6090620 Genes and gene products related to Werner's syndrome |
| 07/18/2000 | US6090618 DNA constructs and viral vectors comprising a smooth muscle promoter |
| 07/18/2000 | US6090612 Polynucleotide sequence coding a phosphatase enzymes; a diagnostic tool for monitoring enzyme activity in sample; for treatment of nervous system disorders, cardiovascular disorders and tumors; antitumor agents |
| 07/18/2000 | US6090583 Expression system in compatible host cell of a polynucleotide which produces a metalloprotease; diagnosis and treatment of asthma, disorders of leukotriene metabolism; anticarcinogenic agents; antiinflammatory/antidiabetic/antiarthritic agents |
| 07/18/2000 | US6090579 Human SDR2 cDNA clone |
| 07/18/2000 | US6090578 Composition comprising at least 75% w/w of human multiple tumor suppressor 1 polypeptide; diagnosis of predisposition for cancer; anticarcinogenic agents; gene therapy |
| 07/18/2000 | US6090576 Nucleotide and amino acid sequences; for diagnosis of infections, immunogens, and vaccines especially against otitis media |
| 07/18/2000 | US6090564 Amino acid sequence of human small nuclear ribonucleoprotein protein; for diagnosis, prevention and treatment of systemic lupus erythematosus |
| 07/18/2000 | US6090554 Efficient construction of gene targeting vectors |
| 07/18/2000 | US6090391 Recombinant tryptophan mutants of influenza |
| 07/18/2000 | US6090383 Monoclonal antibodies to transforming growth factor-β and methods of use |
| 07/18/2000 | US6090382 Human antibodies that bind human TNFα |
| 07/18/2000 | CA2175797C Human kunitz-type protease inhibitors |
| 07/18/2000 | CA2108777C Modified plant viruses as vectors |
| 07/18/2000 | CA2093927C Ligand-mediated immunofunctional hormone binding protein assay method |
| 07/18/2000 | CA1341055C Transfectant cell lines which express the major human rhinovirus receptor |
| 07/13/2000 | WO2000040760A1 Silent inducible virus replicons and uses thereof |
| 07/13/2000 | WO2000040740A2 Gene therapy to promote angiogenesis |
| 07/13/2000 | WO2000040739A2 RIBONUCLEOTIDE REDUCTASE LARGE SUBUNIT (R1) cDNA AND USES THEREOF |
| 07/13/2000 | WO2000040738A1 Co-expression of proteins |
| 07/13/2000 | WO2000040733A1 Human cyclic nucleotide pdes |
| 07/13/2000 | WO2000040729A1 Streptococcal abc transporter protein |
| 07/13/2000 | WO2000040728A1 Nucleic acids and proteins corresponding to mutants of g-csf with granulopoietic activity |
| 07/13/2000 | WO2000040722A2 Insulin-synthesis genes |
| 07/13/2000 | WO2000040721A1 Monocyte-derived nucleic acids and related compositions and methods |
| 07/13/2000 | WO2000040716A2 Soluble receptor br43x2 and methods of using them for therapy |
| 07/13/2000 | WO2000040707A1 Modified forms of hepatitis c virus ns3 protease |
| 07/13/2000 | WO2000040705A2 Human desaturase gene and uses thereof |
| 07/13/2000 | WO2000040702A1 Method for separating viral particles |
| 07/13/2000 | WO2000040701A2 Non-myeloablative tolerogenic treatment |
| 07/13/2000 | WO2000040700A2 Oocyte activation by sperm components |
| 07/13/2000 | WO2000040699A2 Astrocytes, their preparation and uses thereof |
| 07/13/2000 | WO2000040698A1 Pth receptor and screening assay utilizing the same |
| 07/13/2000 | WO2000040694A2 Methods for altering organ mass, controlling fertility and enhancing asexual reproduction in plants |
| 07/13/2000 | WO2000040693A2 Expression of secreted human alpha-fetoprotein in transgenic animals |
| 07/13/2000 | WO2000040616A1 METHODS OF ELICITING BROADLY NEUTRALIZING ANTIBODIES TARGETING HIV-1 gp41 |
| 07/13/2000 | WO2000040615A2 EXPRESSION AND EXPORT OF ANTI-OBESITY PROTEINS AS Fc FUSION PROTEINS |
| 07/13/2000 | WO2000040614A2 Characterization of the soc/crac calcium channel protein family |
| 07/13/2000 | WO2000040607A2 Tiam2 (t-cell lymphoma invasion and metastasis 2) nucleotide exchange factor |
| 07/13/2000 | WO2000040595A1 Antisense modulation of novel anti-apoptotic bcl-2-related proteins |
| 07/13/2000 | WO2000040592A1 Acid stable backbone modified end-blocked nucleic acids and therapeutic uses thereof |
| 07/13/2000 | WO2000040274A1 Metastasis models using green fluorescent protein (gfp) as a marker |